Kidney Transplant Drug Tegoprubart: What the Latest BESTOW Results Could Mean
New long-term trial results suggest the kidney transplant drug Tegoprubart may protect kidney function better than standard Tacrolimus. We explain what it could mean for patients.
Kidney Health: What the New NHS Walking Scheme Could Mean for Patients
The NHS is planning a ‘marathon a month’ walking challenge. Here is what a gentle daily walk could mean for kidney health, and how to build up safely.
A new blood pressure drug wins US approval: what it could mean for kidney patients
A new blood pressure drug called Baxdrostat has been approved in the United States for hard to control hypertension. We look at what it could mean for kidney patients in the years ahead.
Could an MRI scan help predict kidney risk after tumour surgery?
A new US study suggests that advanced MRI scans taken before kidney tumour surgery may help doctors identify which patients are more likely to develop reduced kidney function or chronic kidney disease after their operation. The research is not about routine CKD screening, but about whether imaging can give doctors a clearer picture of kidney reserve before surgery.
Low Protein Diet and CKD: What Promising 2026 Research Suggests
A large international study suggests a modest low protein diet may slow chronic kidney disease and reduce the need for dialysis, without harming nutrition. We look at what it could mean for kidney patients.
Help Improve the Needling Experience: Join the Digital NPREM Study at MRI
The University of Salford is looking for Greater Manchester patients and families to help improve the needling experience for people on haemodialysis. We share how to take part.
Kidney swap transplant: world-first eight-person procedure in 2026
A world-first kidney swap transplant in France paired four donors with four recipients across four hospitals. We explain what it means for UK kidney patients and the UK Living Kidney Sharing Scheme.
Kidney transplant medication: promising monthly infusion trial in 2026
A new UCSF phase 2 trial offers early hope that kidney transplant medication could one day shift from a daily cocktail of tablets to a monthly infusion, with the potential to reduce side effects and protect the donor kidney for longer. We explain what the researchers found and what it could mean for kidney transplant patients in the UK.
APOL1 kidney disease: 2026 research deepens understanding for African heritage families
New research from the University of Ghana sheds light on how the APOL1 gene shapes kidney disease risk in people of West African heritage. We explain what this means for UK patients, why it matters for Greater Manchester communities, and how it points the way to fairer screening and more personal care.
Gout and CKD: New Research on Why Nephrology Care Makes a Difference in 2026
Three new studies presented at NKF 2026 highlight why nephrology care matters for people managing gout and CKD together. Here is what we learned.